ArticleBMC cancer2026
Navigating cancer treatment in people with intellectual disability: a qualitative study of professionals' and family members' perspectives.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCancer occurs in people with intellectual disability (ID) as frequently as in the general population. However, successful cancer treatment is less likely in people with ID, and the underlying reasons are not well-documented. Here we investigated the perspectives of health care professionals (HCPs) and family members regarding cancer care delivery and challenges for people with ID, with the aim of identifying the barriers and facilitators to care.
methodsSemi-structured interviews were conducted with professionals and family members involved in cancer care for adults with ID. The obtained data were subjected to thematic analysis.
resultsThirty-seven interviews were analyzed. Ten barriers to care were identified, four of which emerged from the participants’ accounts. The main identified barriers to care were related to patients’ limitations (psychological, physical, and treatment non-agreement), communication difficulties (i.e., with the patient, or between professionals or institutions), professionals’ lack of knowledge, and advanced cancer stage at diagnosis. Facilitating circumstances were also identified—which included any presence of a proactive family member or professional caregiver, presence of a proactive family member or caregiver throughout the course of treatment, the patient having a confident and positive attitude, and tailored environment.
conclusionWhile barriers related to patient characteristics are unmodifiable, it may be possible to improve professionals’ knowledge, communication skills, the patient’s environment, and diagnostic delays. Thus, many obstacles that complicate cancer treatment for people with ID, and those who care for them, can be alleviated to potentially improve cancer prognosis in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.